2024日本东京制药原料展览会 in-PHARMA JAPAN ●展会时间:2024年06月26-28日 ●展会地点:东京BIGSIGHT展览馆 ●主办单位:励展集团 ●展会周期:一年一届 ●展会规模:展览面积:28000㎡展商数量:570家观众数量:43000人 ●组展单位:上海贸升展览服务有限公司—日本展服务商 不参展人员:我司可提供随团观展服务,提供...
2024年第18届日本国际医药原料及配料展览会in-PHARMA JAPAN(以下简称日本制药展)将于6月26-28日在日本东京big sight会展中心举办,该展会由RX Japan Ltd(励展博览集团前身)主办,是日本超大规模的制药行业综合性展会。 展会同期将举办日本国际医药研发及制造技术展览会(INTERPHEX JAPAN)和日本国际生物制药展览会(BioPharma...
展会时间:2024年06月26-28日;东京Big Sight 展览馆 展会规模:约1850家参展商; 参观人数:约85000名; 主办单位:励展博览集团日本株式会社 组展单位:上海贸升展览服务有限公司--日本展会服务商 同期举办:INTERPHEX JAPAN (制造&包装展),in-Pharma Japan (APIs/药物成分展),BioPharma Expo(生物制药展)和PharmaLab ...
AbbVie headquarters, North Chicago Join us for the Metabolomics in pharma: Bridging R&D translation barriers seminar on October 15, 2024, from 12:00-1:00 pm at AbbVie headquarters in North Chicago, IL. This lunch and learn event, sponsored by biocrates life sciences and hosted by Dr. Qin ...
原料供应商对日本制药产业进行商务洽谈的平台。 这展会是能汇集日本制药市场关键人物的重要活动。如果您是原料供应商想扩大日本市场业务,参展日本国际制药原料及配料展览会(INTERPHEX JAPAN)是很好的选择。 ●参展范围: A、中药 活性医药配料 氨基酸 抗生素 抗菌防腐剂抗氧化剂 生物催化剂 ...
December 20, 2024 Feature ArticleThese professionals in the healthcare marketing sector have been chosen by their peers for making big moves and taking on larger roles. The pharmaceutical industry is undergoing a transformative era, driven by groundbreaking advancements in technology, shifting consumer ...
Discover the key trends in the pharmaceutical industry in 2024-2025 and how AI in pharma is revolutionising the sector. Read more here! In recent years, thepharmaceutical industryhas undergone a significant transformation, greatly accelerated by the COVID-19 pandemic. This health crisis has driven...
Register now to secure your place and become part of the conversation about pharma brand planning in 2024. About the panel Daniel Kohlstaedt, Managing Director, PurpleLeaf Strategy Daniel Kohlstaedt is founder and managing director of PurpleLeaf Strategy and has over 19 years’ extensive experience...
Pharmaceutical ExecutivePharmaceutical Executive: May 2024 Volume 44 Issue 5Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is. ...
#药闻简讯#2024 年 4 月 8日,临床阶段的罕见病生物制药公司$Inozyme Pharma(INZY)$宣布了INZ-701在成人ABCC6缺乏症(PXE,假黄疽弹性体)和ENPP1缺乏症患者中正在进行的1/2期临床试验的安全性、药代动力学(PK)、药效学(PD)和探索性疗效数据。 ABCC6 缺乏症数据 ...